Influenza Virus Infections and Cellular Kinases

por Meineke, Robert, Rimmelzwaan, Guus F., Elbahesh, Husni
Publicado 2019

FDA-approved Abl/EGFR/PDGFR kinase inhibitors show potent efficacy against pandemic and seasonal influenza A virus infections of human lung explants

por Meineke, Robert, Stelz, Sonja, Busch, Maximilian, Werlein, Christopher, Kühnel, Mark, Jonigk, Danny, Rimmelzwaan, Guus F., Elbahesh, Husni
Publicado 2023

Host Responses to Respiratory Syncytial Virus Infection

por Agac, Ayse, Kolbe, Sophie M., Ludlow, Martin, Osterhaus, Albert D. M. E., Meineke, Robert, Rimmelzwaan, Guus F.
Publicado 2023

FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus Infections

por Meineke, Robert, Stelz, Sonja, Busch, Maximilian, Werlein, Christopher, Kühnel, Mark, Jonigk, Danny, Rimmelzwaan, Guus F., Elbahesh, Husni
Publicado 2022